| __timestamp | Intra-Cellular Therapies, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 19586000 |
| Thursday, January 1, 2015 | 87718074 | 29135000 |
| Friday, January 1, 2016 | 93831530 | 42791000 |
| Sunday, January 1, 2017 | 79419009 | 49577000 |
| Monday, January 1, 2018 | 132166913 | 89209000 |
| Tuesday, January 1, 2019 | 89124838 | 69099000 |
| Wednesday, January 1, 2020 | 65782137 | 75961000 |
| Friday, January 1, 2021 | 88845513 | 90467000 |
| Saturday, January 1, 2022 | 134715000 | 74552000 |
| Sunday, January 1, 2023 | 180142000 | 91593000 |
Unleashing insights
In the competitive landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Intra-Cellular Therapies, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated distinct trajectories in their R&D investments. From 2014 to 2023, Intra-Cellular Therapies increased its R&D budget by over 750%, peaking in 2023 with a remarkable 180 million dollars. This surge underscores their commitment to pioneering new therapies. In contrast, Supernus Pharmaceuticals exhibited a steadier growth, with a 370% increase over the same period, reaching approximately 92 million dollars in 2023. This consistent investment reflects a balanced approach to innovation and market expansion. The data highlights the strategic priorities of these companies, offering insights into their potential future breakthroughs and market positioning.
R&D Insights: How Eli Lilly and Company and Intra-Cellular Therapies, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: GSK plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Intra-Cellular Therapies, Inc. and Xenon Pharmaceuticals Inc.
Intra-Cellular Therapies, Inc. or MorphoSys AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Viridian Therapeutics, Inc.
Comparing Innovation Spending: Pharming Group N.V. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for MorphoSys AG and Supernus Pharmaceuticals, Inc.
HUTCHMED (China) Limited vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Supernus Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending